← Browse by Condition
Medical Condition
neuroendocrine cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 1, Phase 2
NCT07458906
Recruiting
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
Enrollment
60 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07080242 Phase 1
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Enrollment
120 pts
Location
United States
Sponsor
SystImmune Inc.
NCT06283719 Phase 1, Phase 2
Recruiting
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
Enrollment
265 pts
Location
China
Sponsor
Suzhou Zelgen Biopharmaceutica...